Euro-Med Laboratories Phil., Inc. Announces Parent Earnings Results for the First Quarter Ended March 31, 2020
June 30, 2020 at 05:21 am EDT
Share
Euro-Med Laboratories Phil., Inc. announced parent earnings results for the first quarter ended March 31, 2020. For the quarter, the company announced net sales of PHP 860,513,232 compared to PHP 874,046,890 a year ago. Net income was PHP 45,949,448 compared to PHP 60,075,809 a year ago. Basic earnings per share was PHP 0.01 compared to PHP 0.01 a year ago.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
EURO-MED LABORATORIES PHIL., INC. 
